The Pharmaceutical Suppositories Market was valued for $1,606.46 million in 2022 and is estimated to reach $2,802.05 million by 2032, exhibiting a CAGR of 5.7% from 2023 to 2032.
Suppositories are solid dosage forms of medication that are precisely designed for insertion into bodily cavities other than the mouth. They can be placed in the rectum, vaginal canal, or urethra. These items are designed to melt or dissolve in the cavity fluids after insertion, allowing the drug to be released. On the basis of the site of insertion, suppositories are divided into rectal suppository, vaginal suppository, and urethral suppository. Suppositories have usefulness in on-site action. It omits the first-pass effect which save drug from metabolism. In case of bitter and obnoxious drugs, suppositories are used as drug delivering option. In pediatrics, suppositories are often used to treat symptoms similar to constipation. However, there is a possibility of mucosal irritation at the site of use which may limit its usage.
The increase in prevalence of chronic diseases that necessitate the use of suppositories is a significant driver for the pharmaceutical suppositories market. Chronic conditions such as inflammatory bowel disease, hemorrhoids, and certain cancers often benefit from localized drug delivery, reducing systemic side effects. The demand for suppository-based treatments rises as these conditions become more common due to various factors such as lifestyle changes and aging populations. For instance, according to the article published in National Library of Medicine, stated that 320,000 people in Canada have been living with Inflammatory bowel disease (IBD), and the prevalence is forecasted to rise by 2.44% per year such 1.1% of the population, 470,000 Canadians, are anticipated to live with IBD by 2035.
This trend offers substantial growth opportunities for pharmaceutical companies, leading to the development of new formulations and expanding the market for suppository-based medications to meet the healthcare needs of individuals with chronic diseases.
However, limited drug compatibility hinders market growth as not all medications are effectively delivered through suppositories due to stability and solubility issues. In addition, manufacturing complexities, requiring specialized equipment and processes, increase production costs and restrict the number of manufacturers, limiting market accessibility and affordability.
The pharmaceutical suppositories market is segmented into type, base, distribution channel, end user, prescription type and region. On the basis of type, the market is divided into rectal suppositories, vaginal suppositories and urethral suppositories. On the basis of base, it is classified into fatty base, water miscible bases, and emulsifying bases. The water miscible bases are further segmented into glycero gelatin base, soap glycerin suppositories, and polyethylene glycol bases. The emulsifying bases are further segmented into witepsol, massa esterium, and massuppol.
On the basis of distribution channel, the market is divided into hospital pharmacies, retail pharmacies and online sales. On the basis of end user, it is classified into hospitals & clinics, home care and nursing home. On the basis of prescription type, it is bifurcated into OTC and prescribed suppositories. On the basis of region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. The major players that operate in the pharmaceutical suppositories market include Bayer AG, Bliss Gvs Pharma Ltd, Viatris Inc, Cadila Healthcare Ltd, Church & Dwight Co., Inc., Glenmark Pharmaceuticals Limited, Intas Pharmaceuticals Ltd., Novartis AG, Pfizer Inc., and Sanofi S.A.
suppositories provide great alternative of drug delivery and can be useful in case of unconscious patients or where direct on-site action is desired.
The factors such as increased geriatric population, rise in number of gastro-intestinal diseases across the globe, rise in intra uterine diseases and various chronic diseases and rise in number of hospitals & clinics are expected to drive the growth of the pharmaceutical suppositories market. Moreover, the increase in use of rectal suppositories and technological advancements further boost the growth of the market.
In addition, North America is expected to witness the highest growth, in terms of revenue, owing to ongoing technological advancements, a well-established and advanced healthcare infrastructure, and adoption of suppositories for treatment by patients and healthcare providers. However, Asia-Pacific is anticipated to witness notable growth, owing to a rise in geriatric population and an increase in initiative to expand the healthcare facilities in the region, thus driving the growth of the market during the forecast period.
Suppositories are solid dosage forms of medication that are precisely designed for insertion into bodily cavities other than the mouth. They can be placed in the rectum, vaginal canal, or urethra. These items are designed to melt or dissolve in the cavity fluids after insertion, allowing the drug to be released. On the basis of the site of insertion, suppositories are divided into rectal suppository, vaginal suppository, and urethral suppository. Suppositories have usefulness in on-site action. It omits the first-pass effect which save drug from metabolism. In case of bitter and obnoxious drugs, suppositories are used as drug delivering option. In pediatrics, suppositories are often used to treat symptoms similar to constipation. However, there is a possibility of mucosal irritation at the site of use which may limit its usage.
The increase in prevalence of chronic diseases that necessitate the use of suppositories is a significant driver for the pharmaceutical suppositories market. Chronic conditions such as inflammatory bowel disease, hemorrhoids, and certain cancers often benefit from localized drug delivery, reducing systemic side effects. The demand for suppository-based treatments rises as these conditions become more common due to various factors such as lifestyle changes and aging populations. For instance, according to the article published in National Library of Medicine, stated that 320,000 people in Canada have been living with Inflammatory bowel disease (IBD), and the prevalence is forecasted to rise by 2.44% per year such 1.1% of the population, 470,000 Canadians, are anticipated to live with IBD by 2035.
This trend offers substantial growth opportunities for pharmaceutical companies, leading to the development of new formulations and expanding the market for suppository-based medications to meet the healthcare needs of individuals with chronic diseases.
However, limited drug compatibility hinders market growth as not all medications are effectively delivered through suppositories due to stability and solubility issues. In addition, manufacturing complexities, requiring specialized equipment and processes, increase production costs and restrict the number of manufacturers, limiting market accessibility and affordability.
The pharmaceutical suppositories market is segmented into type, base, distribution channel, end user, prescription type and region. On the basis of type, the market is divided into rectal suppositories, vaginal suppositories and urethral suppositories. On the basis of base, it is classified into fatty base, water miscible bases, and emulsifying bases. The water miscible bases are further segmented into glycero gelatin base, soap glycerin suppositories, and polyethylene glycol bases. The emulsifying bases are further segmented into witepsol, massa esterium, and massuppol.
On the basis of distribution channel, the market is divided into hospital pharmacies, retail pharmacies and online sales. On the basis of end user, it is classified into hospitals & clinics, home care and nursing home. On the basis of prescription type, it is bifurcated into OTC and prescribed suppositories. On the basis of region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. The major players that operate in the pharmaceutical suppositories market include Bayer AG, Bliss Gvs Pharma Ltd, Viatris Inc, Cadila Healthcare Ltd, Church & Dwight Co., Inc., Glenmark Pharmaceuticals Limited, Intas Pharmaceuticals Ltd., Novartis AG, Pfizer Inc., and Sanofi S.A.
suppositories provide great alternative of drug delivery and can be useful in case of unconscious patients or where direct on-site action is desired.
The factors such as increased geriatric population, rise in number of gastro-intestinal diseases across the globe, rise in intra uterine diseases and various chronic diseases and rise in number of hospitals & clinics are expected to drive the growth of the pharmaceutical suppositories market. Moreover, the increase in use of rectal suppositories and technological advancements further boost the growth of the market.
In addition, North America is expected to witness the highest growth, in terms of revenue, owing to ongoing technological advancements, a well-established and advanced healthcare infrastructure, and adoption of suppositories for treatment by patients and healthcare providers. However, Asia-Pacific is anticipated to witness notable growth, owing to a rise in geriatric population and an increase in initiative to expand the healthcare facilities in the region, thus driving the growth of the market during the forecast period.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the pharmaceutical suppositories market analysis from 2022 to 2032 to identify the prevailing pharmaceutical suppositories market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the pharmaceutical suppositories market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global pharmaceutical suppositories market trends, key players, market segments, application areas, and market growth strategies.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- Regulatory Guidelines
- Additional company profiles with specific to client's interest
- Expanded list for Company Profiles
Key Market Segments
By Type
- Rectal Suppositories
- Vaginal Suppositories
- Urethral Suppositories
By Base
- Fatty Bases
- Water Miscible Base
- Type
- Glycero Gelatin Base
- Soap Glycerin Suppositories
- Polyethylene Glycol Bases
- Emulsifying Bases
- Type
- Witepsol
- Massa Esterium
- Massuppol
By End User
- Hospitals and Clinics
- Home Care
- Nursing Home
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Sales
By Prescription Type
- OTC
- Prescribed Suppositories
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Key Market Players
- Bayer AG
- Church & Dwight Co. Inc.
- Cadila Healthcare Ltd
- Pfizer Inc.
- Intas Pharmaceuticals Ltd.
- Viatris Inc.
- Novartis AG
- Sanofi S.A.
- Bliss GVS Pharma Ltd
- Glenmark Pharmaceuticals Limited
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: PHARMACEUTICAL SUPPOSITORIES MARKET, BY TYPE
CHAPTER 5: PHARMACEUTICAL SUPPOSITORIES MARKET, BY BASE
CHAPTER 6: PHARMACEUTICAL SUPPOSITORIES MARKET, BY DISTRIBUTION CHANNEL
CHAPTER 7: PHARMACEUTICAL SUPPOSITORIES MARKET, BY END USER
CHAPTER 8: PHARMACEUTICAL SUPPOSITORIES MARKET, BY PRESCRIPTION TYPE
CHAPTER 9: PHARMACEUTICAL SUPPOSITORIES MARKET, BY REGION
CHAPTER 10: COMPETITIVE LANDSCAPE
CHAPTER 11: COMPANY PROFILES
List of Tables
List of Figures
Executive Summary
According to the report, the pharmaceutical suppositories market was valued at $1.6 billion in 2022, and is estimated to reach $2.8 billion by 2032, growing at a CAGR of 5.7% from 2023 to 2032.The pharmaceutical suppositories market is likely to experience a significant growth rate of 5.7% from 2023-2032 owing to increasing market demand of rectal suppositories segment
Pharmaceutical suppositories are solid, medicated dosage forms designed for rectal or vaginal administration. These small, often bullet-shaped units contain active pharmaceutical ingredients (APIs) dispersed in a suitable base material. When inserted into the body, they gradually melt or dissolve, allowing for the controlled release and absorption of the medication. Suppositories are used in medical practice to deliver localized treatment, bypass the first-pass metabolism in the liver, and offer an alternative when oral or intravenous routes are not ideal. They are employed in a wide range of medical conditions, including pain management, gastrointestinal issues, hormone therapy, and more, providing targeted drug delivery with minimized systemic effects.The pharmaceutical suppositories market is experiencing significant growth driven by the growing prevalence of the geriatric population and the increasing incidence of acute and chronic diseases. As the world's population continues to age, there is a substantial rise in the number of elderly individuals who often require specialized medical treatments. Suppositories offer an effective and targeted drug delivery method, which is especially beneficial for older adults who may have difficulty swallowing or need localized treatment.
Moreover, the surge in acute and chronic diseases worldwide has bolstered the demand for suppositories. These dosage forms are crucial in managing various conditions such as constipation, pain, hemorrhoids, and inflammatory bowel diseases. For instance, according to the article published in Springer, in 2023, it states that average prevalence of constipation was estimated at 16% globally, while a prevalence of 33.5% was attributed to adults between 60 and 110 years old. This underscores the importance of suppositories in addressing healthcare needs, contributing to the growth of the pharmaceutical suppositories market as they provide effective solutions for patients of all ages.
Furthermore, the growing initiative taken by key players and the government organizations for awareness regarding use of suppositories are further driving the market growth. These initiatives are pivotal in market expansion by educating both healthcare professionals and the general public about the benefits and applications of suppository-based medications. By providing information and promoting the safe and effective use of suppositories, these stakeholders contribute to increased acceptance and utilization of this drug delivery method. Patients become more aware of the advantages of suppositories, while healthcare providers gain confidence in prescribing and administering them. This combined effort fosters a conducive environment for the pharmaceutical suppositories market to thrive, ultimately benefiting individuals who can benefit from these specialized and targeted treatment options.
The global pharmaceutical suppositories market is segmented based on type, base, distribution channel, end user, prescription type and region. On the basis of type, the market is divided into rectal suppositories, vaginal suppositories and urethral suppositories. On the basis of base, it is classified into fatty base, water miscible bases, and emulsifying bases. The water miscible bases are further segmented into glycero gelatin base, soap glycerin suppositories, and polyethylene glycol bases. The emulsifying bases are further segmented into witepsol, massa esterium, and massuppol. On the basis of distribution channel, the market is divided into hospital pharmacies, retail pharmacies and online sales. On the basis of end user, it is classified into hospitals & clinics, home care and nursing home. On the basis of prescription type, it is bifurcated into OTC and prescribed suppositories. On the basis of region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The report provides a comprehensive analysis of the key players that operate in the global pharmaceutical suppositories market such as Bayer AG, Bliss Gvs Pharma Ltd, Viatris Inc, Cadila Healthcare Ltd, Church & Dwight Co., Inc., Glenmark Pharmaceuticals Limited, Intas Pharmaceuticals Ltd., Novartis AG, Pfizer Inc., and Sanofi S.A. Key players operating in the market have adopted product approval as their key strategies to expand their product portfolio.
Key Market Insights (Updated)
- On the basis of type, the rectal suppositories segment dominated the market in terms of revenue in 2022. However, the vaginal suppositories segment is anticipated to grow at the fastest CAGR during the forecast period.
- On the basis of base, the emulsifying bases segment held largest market share in 2022 and is expected to remain dominant throughout the forecast period.
- On the basis of distribution channel, the hospital pharmacies segment dominated the market in terms of revenue in 2022. However, the online sales segment is anticipated to grow at the fastest CAGR during the forecast period.
- On the basis of end user, the hospitals & clinics segment dominated the market in terms of revenue in 2022. However, the home care segment is anticipated to grow at the fastest CAGR during the forecast period.
- On the basis of prescription type, the prescribed suppositories segment held the largest market share in 2022. However, the OTC segment is anticipated to grow at the fastest CAGR during the forecast period.
- On the basis of region, North America generated the largest revenue in 2022. However, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.
Companies Mentioned
- Bayer AG
- Church & Dwight Co. Inc.
- Cadila Healthcare Ltd
- Pfizer Inc.
- Intas Pharmaceuticals Ltd.
- Viatris Inc.
- Novartis AG
- Sanofi S.A.
- Bliss GVS Pharma Ltd
- Glenmark Pharmaceuticals Limited
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
